Study questions routine ibuprofen for preemie heart condition
NCT ID NCT07533721
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 541 premature babies with a heart condition called patent ductus arteriosus (PDA). Half received ibuprofen to close the vessel, while the other half got only supportive care like fluids or diuretics. Researchers compared closure rates and complications to see which approach works better for different gestational ages.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ibuprofen
What this could lead to
If successful, this could help doctors decide whether to use ibuprofen or simply monitor premature babies with a common heart condition, potentially reducing unnecessary drug exposure.
What could go wrong
This is a retrospective study, not a randomized trial, so results may be influenced by unmeasured factors. The findings may not apply to all hospitals or patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFANT, PREMATURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China